Cargando…

Lipoic Acid Attenuates Inflammation via cAMP and Protein Kinase A Signaling

BACKGROUND: Abnormal regulation of the inflammatory response is an important component of diseases such as diabetes, Alzheimer's disease and multiple sclerosis (MS). Lipoic acid (LA) has been shown to have antioxidant and anti-inflammatory properties and is being pursued as a therapy for these...

Descripción completa

Detalles Bibliográficos
Autores principales: Salinthone, Sonemany, Yadav, Vijayshree, Schillace, Robynn V., Bourdette, Dennis N., Carr, Daniel W.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2946928/
https://www.ncbi.nlm.nih.gov/pubmed/20927401
http://dx.doi.org/10.1371/journal.pone.0013058
_version_ 1782187348104052736
author Salinthone, Sonemany
Yadav, Vijayshree
Schillace, Robynn V.
Bourdette, Dennis N.
Carr, Daniel W.
author_facet Salinthone, Sonemany
Yadav, Vijayshree
Schillace, Robynn V.
Bourdette, Dennis N.
Carr, Daniel W.
author_sort Salinthone, Sonemany
collection PubMed
description BACKGROUND: Abnormal regulation of the inflammatory response is an important component of diseases such as diabetes, Alzheimer's disease and multiple sclerosis (MS). Lipoic acid (LA) has been shown to have antioxidant and anti-inflammatory properties and is being pursued as a therapy for these diseases. We first reported that LA stimulates cAMP production via activation of G-protein coupled receptors and adenylyl cyclases. LA also suppressed NK cell activation and cytotoxicity. In this study we present evidence supporting the hypothesis that the anti-inflammatory properties of LA are mediated by the cAMP/PKA signaling cascade. Additionally, we show that LA oral administration elevates cAMP levels in MS subjects. METHODOLOGY/PRINCIPAL FINDINGS: We determined the effects of LA on IL-6, IL-17 and IL-10 secretion using ELISAs. Treatment with 50 µg/ml and 100 µg/ml LA significantly reduced IL-6 levels by 19 and 34%, respectively, in T cell enriched PBMCs. IL-17 levels were also reduced by 35 and 50%, respectively. Though not significant, LA appeared to have a biphasic effect on IL-10 production. Thymidine incorporation studies showed LA inhibited T cell proliferation by 90%. T-cell activation was reduced by 50% as measured by IL-2 secretion. Western blot analysis showed that LA treatment increased phosphorylation of Lck, a downstream effector of protein kinase A. Pretreatment with a peptide inhibitor of PKA, PKI, blocked LA inhibition of IL-2 and IFN gamma production, indicating that PKA mediates these responses. Oral administration of 1200 mg LA to MS subjects resulted in increased cAMP levels in PBMCs four hours after ingestion. Average cAMP levels in 20 subjects were 43% higher than baseline. CONCLUSIONS/SIGNIFICANCE: Oral administration of LA in vivo resulted in significant increases in cAMP concentration. The anti-inflammatory effects of LA are mediated in part by the cAMP/PKA signaling cascade. These novel findings enhance our understanding of the mechanisms of action of LA.
format Text
id pubmed-2946928
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-29469282010-10-06 Lipoic Acid Attenuates Inflammation via cAMP and Protein Kinase A Signaling Salinthone, Sonemany Yadav, Vijayshree Schillace, Robynn V. Bourdette, Dennis N. Carr, Daniel W. PLoS One Research Article BACKGROUND: Abnormal regulation of the inflammatory response is an important component of diseases such as diabetes, Alzheimer's disease and multiple sclerosis (MS). Lipoic acid (LA) has been shown to have antioxidant and anti-inflammatory properties and is being pursued as a therapy for these diseases. We first reported that LA stimulates cAMP production via activation of G-protein coupled receptors and adenylyl cyclases. LA also suppressed NK cell activation and cytotoxicity. In this study we present evidence supporting the hypothesis that the anti-inflammatory properties of LA are mediated by the cAMP/PKA signaling cascade. Additionally, we show that LA oral administration elevates cAMP levels in MS subjects. METHODOLOGY/PRINCIPAL FINDINGS: We determined the effects of LA on IL-6, IL-17 and IL-10 secretion using ELISAs. Treatment with 50 µg/ml and 100 µg/ml LA significantly reduced IL-6 levels by 19 and 34%, respectively, in T cell enriched PBMCs. IL-17 levels were also reduced by 35 and 50%, respectively. Though not significant, LA appeared to have a biphasic effect on IL-10 production. Thymidine incorporation studies showed LA inhibited T cell proliferation by 90%. T-cell activation was reduced by 50% as measured by IL-2 secretion. Western blot analysis showed that LA treatment increased phosphorylation of Lck, a downstream effector of protein kinase A. Pretreatment with a peptide inhibitor of PKA, PKI, blocked LA inhibition of IL-2 and IFN gamma production, indicating that PKA mediates these responses. Oral administration of 1200 mg LA to MS subjects resulted in increased cAMP levels in PBMCs four hours after ingestion. Average cAMP levels in 20 subjects were 43% higher than baseline. CONCLUSIONS/SIGNIFICANCE: Oral administration of LA in vivo resulted in significant increases in cAMP concentration. The anti-inflammatory effects of LA are mediated in part by the cAMP/PKA signaling cascade. These novel findings enhance our understanding of the mechanisms of action of LA. Public Library of Science 2010-09-28 /pmc/articles/PMC2946928/ /pubmed/20927401 http://dx.doi.org/10.1371/journal.pone.0013058 Text en This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. https://creativecommons.org/publicdomain/zero/1.0/ This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration, which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
spellingShingle Research Article
Salinthone, Sonemany
Yadav, Vijayshree
Schillace, Robynn V.
Bourdette, Dennis N.
Carr, Daniel W.
Lipoic Acid Attenuates Inflammation via cAMP and Protein Kinase A Signaling
title Lipoic Acid Attenuates Inflammation via cAMP and Protein Kinase A Signaling
title_full Lipoic Acid Attenuates Inflammation via cAMP and Protein Kinase A Signaling
title_fullStr Lipoic Acid Attenuates Inflammation via cAMP and Protein Kinase A Signaling
title_full_unstemmed Lipoic Acid Attenuates Inflammation via cAMP and Protein Kinase A Signaling
title_short Lipoic Acid Attenuates Inflammation via cAMP and Protein Kinase A Signaling
title_sort lipoic acid attenuates inflammation via camp and protein kinase a signaling
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2946928/
https://www.ncbi.nlm.nih.gov/pubmed/20927401
http://dx.doi.org/10.1371/journal.pone.0013058
work_keys_str_mv AT salinthonesonemany lipoicacidattenuatesinflammationviacampandproteinkinaseasignaling
AT yadavvijayshree lipoicacidattenuatesinflammationviacampandproteinkinaseasignaling
AT schillacerobynnv lipoicacidattenuatesinflammationviacampandproteinkinaseasignaling
AT bourdettedennisn lipoicacidattenuatesinflammationviacampandproteinkinaseasignaling
AT carrdanielw lipoicacidattenuatesinflammationviacampandproteinkinaseasignaling